Is the risk of ovarian malignancy algorithm better than other tests for predicting ovarian malignancy in women with pelvic masses?

M Yanaranop, V Anakrat, S Siricharoenthai… - Gynecologic and …, 2017 - karger.com
Aim: The study aimed to compare the risk of ovarian malignancy algorithm (ROMA) with risk
of malignancy index (RMI), cancer antigen 125 (CA125), human epididymis protein 4 (HE4) …

Rajavithi-ovarian cancer predictive score (R-OPS): A new scoring system for predicting ovarian malignancy in women presenting with a pelvic mass

M Yanaranop, J Tiyayon, S Siricharoenthai… - Gynecologic …, 2016 - Elsevier
Objective To develop a new scoring system based on menopausal status, ultrasound (US)
findings, serum cancer antigen 125 (CA125) and human epididymis protein 4 (HE4) to …

[PDF][PDF] Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy

M Yanaranop, N Sathapornteera, S Nakrangsee - J Med Assoc Thai, 2014 - thaiscience.info
Background: Lymph node metastasis is the most important prognostic factor in cervical
cancer patients. However, most of the available knowledge about risk factors of pelvic nodal …

Significance of serum human epididymis protein 4 and cancer antigen 125 in distinguishing type I and type II epithelial ovarian cancers

M Yanaranop, N Jantarateptewan, J Tiyayon… - International Journal of …, 2018 - ijgc.bmj.com
Objective The objective of this study was to assess the effectiveness of human epididymis
protein 4 (HE4) and cancer antigen 125 (CA125), and risk of ovarian malignancy algorithm …

[PDF][PDF] Cytopathology Reporting using the New Bethesda System of Thyroid FNAC and Correlation with Histopathological Follow-up: A Three-Year Study of Routine …

S Nakrangsee - Journal of the Medical Association of Thailand, 2018 - thaiscience.info
Background: The new Bethesda system for reporting thyroid cytopathology (TBSRTC) was a
major step towards standardization, reproducibility and clarity of communication in thyroid …

[PDF][PDF] Differential diagnosis between primary endocervical and endometrial adenocarcinoma using immunohistochemical staining of estrogen receptor, vimentin …

M Yanaranop, S Ayuwat, S Nakrangsee - J Med Assoc Thai, 2016 - thaiscience.info
Background: When clinical and histopathological evaluation is not effective in discriminating
primary endocervical adenocarcinoma (ECAs) and endometrial adenocarcinoma (EMAs) …

[PDF][PDF] Diagnostic Accuracy and Optimal Cutoff Value of Serum HE4 to Predict Ovarian Cancer in Thai Women with Pelvic Masses.

M Yanaranop, J Tiyayon, S Nakrangsee… - Journal of the Medical …, 2016 - thaiscience.info
Background: Serum human epididymis protein 4 (HE4) is highly expressed in women with
ovarian cancers (OCs), but data about its clinical application of HE4 for Thai women is …

[PDF][PDF] Comparison of Survival Outcomes in Early Stage Invasive Adenocarcinoma with Squamous Cell Carcinoma of the Uterine Cervix

M Yanaranop, S Tuipae, S Nakrangsee - J Med Assoc Thai, 2017 - thaiscience.info
Background: Invasive adenocarcinoma (AC) is the second most common carcinoma of the
uterine cervix; however, it is not clear whether this histologic type influences survival …

[DOC][DOC] Comparison of Risk of Malignancy Index (RMI), CA125, HE4, Risk of Ovarian Malignancy Algorithm (ROMA) and Ultrasound Score for Predictive Ovarian …

M Yanaranop, V Anakrat, S Siricharoenthai… - classroom.takasila.org
Background: Ovarian cancer is the third most common of gynecologic cancer and the
second leading cause of gynecologic cancer-related death. Preoperative prediction of …

[DOC][DOC] E-Mail: myanaran@ hotmail. com

M Yanaranop, V Anakrat, S Siricharoenthai… - classroom.takasila.org
Background: Epithelial ovarian cancer (EOC) is the second most common of gynecologic
cancer and the leading cause of gynecologic cancer-related death. In 2008, 225,000 new …